Recruiting PHASE2 INTERVENTIONAL 1-arm NCT04192253

Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize) (VULCANize)

Sponsor: The Netherlands Cancer Institute

Conditions Locally Advanced, Squamous Cell Carcinoma of the Vulva

Interventions Paclitaxel and Carboplatin

Updated 7 times since 2020 Last updated: Oct 18, 2022 Started: Jan 14, 2020 Primary completion: Jan 1, 2024 Completion: Jan 1, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04192253, this PHASE2 trial focuses on Locally Advanced, Squamous Cell Carcinoma of the Vulva and remains actively recruiting participants. Sponsored by The Netherlands Cancer Institute, it has been updated 7 times since 2020, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Nov 2022 — Jul 2024 [monthly]

Recruiting PHASE2
Jan 2021 — Nov 2022 [monthly]

Recruiting PHASE2
Jul 2020 — Jan 2021 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

Feb 2020 — Jul 2020 [monthly]

Not Yet Recruiting PHASE2
Jan 2020 — Feb 2020 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Netherlands Cancer Institute

Data source: The Netherlands Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Amsterdam, Netherlands